• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒对胰腺胰岛的浸润。

Viral infiltration of pancreatic islets in patients with COVID-19.

机构信息

Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Institute of Virology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

出版信息

Nat Commun. 2021 Jun 10;12(1):3534. doi: 10.1038/s41467-021-23886-3.

DOI:10.1038/s41467-021-23886-3
PMID:34112801
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8192507/
Abstract

Metabolic diseases are associated with an increased risk of severe COVID-19 and conversely, new-onset hyperglycemia and complications of preexisting diabetes have been observed in COVID-19 patients. Here, we performed a comprehensive analysis of pancreatic autopsy tissue from COVID-19 patients using immunofluorescence, immunohistochemistry, RNA scope and electron microscopy and detected SARS-CoV-2 viral infiltration of beta-cells in all patients. Using SARS-CoV-2 pseudoviruses, we confirmed that isolated human islet cells are permissive to infection. In eleven COVID-19 patients, we examined the expression of ACE2, TMPRSS and other receptors and factors, such as DPP4, HMBG1 and NRP1, that might facilitate virus entry. Whereas 70% of the COVID-19 patients expressed ACE2 in the vasculature, only 30% displayed ACE2-expression in beta-cells. Even in the absence of manifest new-onset diabetes, necroptotic cell death, immune cell infiltration and SARS-CoV-2 viral infection of pancreatic beta-cells may contribute to varying degrees of metabolic dysregulation in patients with COVID-19.

摘要

代谢疾病与 COVID-19 重症风险增加相关,相反,COVID-19 患者中也观察到新发高血糖和原有糖尿病并发症。在这里,我们使用免疫荧光、免疫组织化学、RNA 原位杂交和电子显微镜对 COVID-19 患者的胰腺尸检组织进行了全面分析,在所有患者中均检测到 SARS-CoV-2 病毒对β细胞的浸润。使用 SARS-CoV-2 假病毒,我们证实分离的人胰岛细胞允许感染。在 11 名 COVID-19 患者中,我们检测了 ACE2、TMPRSS 及其他可能促进病毒进入的受体和因子,如 DPP4、HMBG1 和 NRP1 的表达。尽管 70%的 COVID-19 患者血管中表达 ACE2,但只有 30%的患者β细胞中表达 ACE2。即使没有明显的新发糖尿病,细胞坏死性死亡、免疫细胞浸润和 SARS-CoV-2 病毒对胰腺β细胞的感染,也可能导致 COVID-19 患者出现不同程度的代谢失调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2364/8192507/25ff1a424ac8/41467_2021_23886_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2364/8192507/281d29df3c91/41467_2021_23886_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2364/8192507/09ec60764ec3/41467_2021_23886_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2364/8192507/342fae61d571/41467_2021_23886_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2364/8192507/25ff1a424ac8/41467_2021_23886_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2364/8192507/281d29df3c91/41467_2021_23886_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2364/8192507/09ec60764ec3/41467_2021_23886_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2364/8192507/342fae61d571/41467_2021_23886_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2364/8192507/25ff1a424ac8/41467_2021_23886_Fig4_HTML.jpg

相似文献

1
Viral infiltration of pancreatic islets in patients with COVID-19.新冠病毒对胰腺胰岛的浸润。
Nat Commun. 2021 Jun 10;12(1):3534. doi: 10.1038/s41467-021-23886-3.
2
SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment.SARS-CoV-2 感染人类胰腺 β 细胞并引起 β 细胞损伤。
Cell Metab. 2021 Aug 3;33(8):1565-1576.e5. doi: 10.1016/j.cmet.2021.05.013. Epub 2021 May 18.
3
SARS-CoV-2 and pancreas: a potential pathological interaction?SARS-CoV-2 与胰腺:一种潜在的病理性相互作用?
Trends Endocrinol Metab. 2021 Nov;32(11):842-845. doi: 10.1016/j.tem.2021.07.004. Epub 2021 Jul 24.
4
SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic -Cells and in the Human Pancreas Microvasculature.SARS-CoV-2 受体血管紧张素转化酶 2(ACE2)在人胰腺细胞和人胰腺微血管中表达。
Front Endocrinol (Lausanne). 2020 Nov 13;11:596898. doi: 10.3389/fendo.2020.596898. eCollection 2020.
5
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.糖尿病中糖化 ACE2 受体:SARS-COV-2 进入心肌细胞的门户。
Cardiovasc Diabetol. 2021 May 7;20(1):99. doi: 10.1186/s12933-021-01286-7.
6
Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.冠状病毒感染与 2 型糖尿病:具有治疗意义的共同途径。
Endocr Rev. 2020 Jun 1;41(3). doi: 10.1210/endrev/bnaa011.
7
Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2.在胰岛中传播:SARS-CoV-2 进入的介质超越 ACE2。
J Mol Endocrinol. 2022 Jun 17;69(2):R63-R79. doi: 10.1530/JME-21-0282.
8
Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.大鼠上下呼吸道中 ACE2 和 TMPRSS2 蛋白的表达:对 COVID-19 感染的影响。
Laryngoscope. 2021 Mar;131(3):E932-E939. doi: 10.1002/lary.29132. Epub 2020 Oct 19.
9
The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues.SARS-CoV-2 受体 ACE2 和 CD147 以及蛋白酶 TMPRSS2 在人源和鼠源脑细胞及鼠脑组织中的表达。
Biochem Biophys Res Commun. 2020 Dec 17;533(4):867-871. doi: 10.1016/j.bbrc.2020.09.042. Epub 2020 Sep 14.
10
Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker-Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19.肺和肾脏 ACE2 和 TMPRSS2 在肾素-血管紧张素系统阻滞剂治疗的伴糖尿病小鼠中的表达,模拟了与严重 COVID-19 相关的宿主因素。
Diabetes. 2021 Mar;70(3):759-771. doi: 10.2337/db20-0765. Epub 2020 Dec 11.

引用本文的文献

1
Increased Incidence of New-Onset Diabetic Retinopathy in Individuals with COVID-19 in an Underserved Urban Population in the Bronx.纽约市布朗克斯区一个服务欠缺的城市人口中,感染新冠病毒的个体新发糖尿病视网膜病变的发病率增加。
Diagnostics (Basel). 2025 Jul 22;15(15):1846. doi: 10.3390/diagnostics15151846.
2
Type I Diabetes-A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection.1型糖尿病——接受免疫治疗患者中描述的一种罕见不良事件与SARS-CoV-2感染的一种副作用。
Reports (MDPI). 2025 Mar 14;8(1):31. doi: 10.3390/reports8010031.
3
Aspirin reduces the risk of type 2 diabetes associated with COVID-19.

本文引用的文献

1
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas.SARS-CoV-2 感染并在人体内分泌和外分泌胰腺细胞中复制。
Nat Metab. 2021 Feb;3(2):149-165. doi: 10.1038/s42255-021-00347-1. Epub 2021 Feb 3.
2
Can COVID-19 cause diabetes?新冠病毒会引发糖尿病吗?
Nat Metab. 2021 Feb;3(2):123-125. doi: 10.1038/s42255-020-00339-7.
3
SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic -Cells and in the Human Pancreas Microvasculature.SARS-CoV-2 受体血管紧张素转化酶 2(ACE2)在人胰腺细胞和人胰腺微血管中表达。
阿司匹林可降低与新冠病毒相关的2型糖尿病风险。
NPJ Metab Health Dis. 2025 Jun 18;3(1):27. doi: 10.1038/s44324-025-00072-3.
4
Angiotensin‑converting enzyme 2 expression in human tumors: Implications for prognosis and therapy (Review).血管紧张素转换酶2在人类肿瘤中的表达:对预后和治疗的影响(综述)
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8934. Epub 2025 Jun 27.
5
Post-COVID Metabolic Fallout: A Growing Threat of New-Onset and Exacerbated Diabetes.新冠后代谢后遗症:新发和加重型糖尿病的威胁日益增加。
Biomedicines. 2025 Jun 16;13(6):1482. doi: 10.3390/biomedicines13061482.
6
Understanding the interplay between COVID-19 and diabetes: insights for the post-pandemic era.了解2019冠状病毒病与糖尿病之间的相互作用:大流行后时代的见解。
Front Endocrinol (Lausanne). 2025 May 21;16:1599969. doi: 10.3389/fendo.2025.1599969. eCollection 2025.
7
New Onset of Type 1 and Type 2 Diabetes Post-COVID-19 Infection: A Systematic Review.新冠病毒感染后1型和2型糖尿病的新发:一项系统综述
Emerg Microbes Infect. 2025 May 6:2492211. doi: 10.1080/22221751.2025.2492211.
8
The Perfect Storm: Co-occurrence of Agranulocytosis and Thyroid Storm Successfully Managed with Lithium Therapy.完美风暴:粒细胞缺乏症与甲状腺危象同时出现,锂盐疗法成功应对
J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251336657. doi: 10.1177/23247096251336657. Epub 2025 Apr 25.
9
Coronavirus endoribonuclease antagonizes ZBP1-mediated necroptosis and delays multiple cell death pathways.冠状病毒内切核糖核酸酶拮抗ZBP1介导的坏死性凋亡并延迟多种细胞死亡途径。
Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2419620122. doi: 10.1073/pnas.2419620122. Epub 2025 Mar 4.
10
Impact of COVID-19 on metabolic parameters in patients with type 2 diabetes mellitus.2019冠状病毒病对2型糖尿病患者代谢参数的影响。
BMC Pulm Med. 2025 Feb 3;25(1):58. doi: 10.1186/s12890-025-03529-9.
Front Endocrinol (Lausanne). 2020 Nov 13;11:596898. doi: 10.3389/fendo.2020.596898. eCollection 2020.
4
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells.SARS-CoV-2 细胞进入因子 ACE2 和 TMPRSS2 表达于人类胰腺的微血管和导管中,但在β细胞中并不丰富。
Cell Metab. 2020 Dec 1;32(6):1028-1040.e4. doi: 10.1016/j.cmet.2020.11.006. Epub 2020 Nov 13.
5
Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19.新型冠状病毒在正常器官捐献者和新冠肺炎患者胰腺中的表达。
Cell Metab. 2020 Dec 1;32(6):1041-1051.e6. doi: 10.1016/j.cmet.2020.11.005. Epub 2020 Nov 13.
6
An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms.COVID-19 的一种即时和长期并发症可能是 2 型糖尿病:β 细胞功能障碍、细胞凋亡的核心作用及可能机制的探讨。
Cells. 2020 Nov 13;9(11):2475. doi: 10.3390/cells9112475.
7
New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19.一名患有新型冠状病毒肺炎相关多系统炎症综合征的儿童新发糖尿病并伴有糖尿病酮症酸中毒。
J Pediatr Endocrinol Metab. 2020 Nov 12;34(1):147-150. doi: 10.1515/jpem-2020-0426. Print 2021 Jan 27.
8
IAP inhibitor, Embelin increases VCAM-1 levels on the endothelium, producing lymphocytic infiltration and antitumor immunity.IAP抑制剂余甘子亭可提高内皮细胞上VCAM-1的水平,产生淋巴细胞浸润和抗肿瘤免疫力。
Oncoimmunology. 2020 Oct 27;9(1):1838812. doi: 10.1080/2162402X.2020.1838812.
9
Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.全基因组 CRISPR 筛选揭示了宿主感染 SARS-CoV-2 的关键因素。
Cell. 2021 Jan 7;184(1):76-91.e13. doi: 10.1016/j.cell.2020.10.028. Epub 2020 Oct 20.
10
Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series.2019冠状病毒病感染引发的糖尿病酮症酸中毒:病例系列
Curr Ther Res Clin Exp. 2020;93:100609. doi: 10.1016/j.curtheres.2020.100609. Epub 2020 Oct 27.